HALIMA ARCHER-IDODO: Open Payments
NPI 1386299261 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 27 payments from 12 companies in 2025. Trend: 2023 $17 · 2024 $714 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $196 |
| Novartis Pharmaceuticals Corporation | 4 | $157 |
| E.R. Squibb & Sons, L.L.C. | 2 | $137 |
| UCB, Inc. | 5 | $131 |
| Amgen Inc. | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Galderma Laboratories, L.P. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $27 |
| Krystal Biotech Inc | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
Products named: DUPIXENT, Sotyktu, Bimzelx, Otezla, LIBTAYO, NEMLUVIO, TREMFYA, COSENTYX.
Industry payments across TX — which companies pay providers there.
